首页 › 基金 › Sofinnova Investments, Inc. › NRIX

Sofinnova Investments, Inc. 对 NRIX 的持仓历史

NURIX THERAPEUTICS INC · 医疗保健

Sofinnova Investments, Inc. 在 Q2 2026 的 13F 申报中披露持有 NRIX(NURIX THERAPEUTICS INC)524,098 股,市值约 US$12.7M,约占其申报组合的 0.68%,在其申报持仓中市值排名第 34 位。 Sofinnova Investments, Inc. 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)524.10K 股
申报持仓市值$12.71M
组合权重0.68%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Sofinnova Investments, Inc. 对 NRIX 的持仓演变

Sofinnova Investments, Inc. 于 Q2 2026 首次披露 NRIX 持仓:524,098 股(约 US$12.7M)。

逐季持仓明细

季度股数金额变化
Q2 2026 524.10K $12.71M 新进

关于 NRIX 与 13F 数据

NRIX(NURIX THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 NRIX,申报仓位最大的包括:Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NRIX 的基金

查看 NRIX 的全部基金持有人 →

常见问题

How long has Sofinnova Investments, Inc. held NRIX?

Sofinnova Investments, Inc. has disclosed NRIX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Sofinnova Investments, Inc.'s current position in NRIX?

As of Q2 2026, Sofinnova Investments, Inc. holds 524.10K shares of NRIX (NURIX THERAPEUTICS INC), valued at $12.71M, representing 0.68% of its reported portfolio and ranking #34.

Has Sofinnova Investments, Inc. been buying or selling NRIX?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in NRIX.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.